| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |